What is PainTEQ?
Founded in 2013 and headquartered in Tampa, Florida, PainTEQ occupies a critical niche in the orthopedic and pain management landscape. The company specializes in minimally invasive procedures designed to address chronic back pain and sacroiliac joint dysfunction. By providing surgeons with advanced implant systems, PainTEQ has successfully facilitated over 14,000 procedures, establishing a proven track record of clinical efficacy. Its market position is defined by a commitment to reducing the invasiveness of traditional spinal interventions, thereby improving patient recovery times and overall quality of life. The company's focus on evidence-based medical technology has allowed it to capture significant market share within the interventional pain management vertical.
How much funding has PainTEQ raised?
PainTEQ has raised a total of $35M across 1 funding round:
Debt
$35M
Debt (2023): $35M with participation from Mvolution Partners
Key Investors in PainTEQ
Mvolution Partners
A specialized investment firm focused on providing debt financing and strategic capital to high-growth healthcare and medical technology companies.
What's next for PainTEQ?
With the recent injection of capital, PainTEQ is well-positioned to accelerate its commercial expansion and deepen its research and development pipeline. The company is expected to leverage this major enterprise-level funding to enhance its distribution networks and potentially explore new indications for its proprietary implant systems. As the healthcare industry continues to prioritize value-based care and minimally invasive surgical alternatives, PainTEQ's strategic focus on SI joint dysfunction provides a clear pathway for sustained growth. Future initiatives will likely center on scaling operational capacity to support the increasing volume of procedures, while maintaining the rigorous clinical standards that have defined its growth to date. The firm remains a key player to watch as it navigates the complexities of the medical device market and seeks to solidify its leadership in the interventional pain space.
See full PainTEQ company page
